Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF
{{output}}
Aims: Heart failure with preserved ejection fraction (HFpEF) causes substantial morbidity and mortality. Importantly, atrial remodeling and atrial fibrillation is frequently observed in HFpEF. Sodium-glucose cotransporter 2 inhib... ...
